Register today to access recent news and articles.

Starling secures US$25m SLR revolver against receivables as first US$4.75m is drawn

Starling Oncology has put a US$25m revolving facility in place with SLR Healthcare ABL, using an accounts-receivable borrowing base to provide working-capital liquidity across its oncology operations. Starling Oncology Management…

Sign in or Upgrade to Continue Reading

This news article is over 10 days old. Subscribe today to access all articles with an annual subscription.

Already a subscriber?

To top
BCR Publishing
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.